Novo Nordisk has dropped “Nordisk” from its everyday name and redrawn its century-old bull logo, and a Danish communications adviser calls the result a solid piece of work.
The Danish pharmaceutical company presented the new name and visual identity on September 13, 2026. DR reports that the company will market itself simply as Novo, with an updated logo and a new slogan, “Lasting health starts now.”
Sune Bang, an independent communications adviser with more than 30 years in the industry, assessed the change for DR. Per Bang, this is not a revolution but a classic tightening and simplification that makes the identity easier to read. He described it as a signal to the market that a new reality has arrived.
TV 2 reports that Novo Nordisk A/S remains the legal name of the company globally. According to TV 2, the updated identity keeps the historic Apis bull but turns it to face right, simplifies the colors and shortens the tail.
The bull now looks forward
The Apis bull, a sacred animal in ancient Egypt symbolizing fertility and strength, has appeared in the logo since 1923. Bang reads the new direction as a company looking ahead at opportunities in a new market. He contrasts that with looking back at Novo’s large share of the diabetes medicine market.
As noted by Bang, the change reflects the commercialization the company is now pursuing. He said Novo is becoming a brand rather than a company, because it must sell directly to consumers and not only to the health industry. He added that Novo has kept its identity despite removing “Nordisk” from the name.
Bang also reads the removal as an accommodation toward the United States. He said the word “Nordisk” may not stand particularly strong on the global market at the moment, especially in the U.S. He pointed to chief executive Mike Doustdar, who said at the White House that Novo has in a strange way been more American, despite its Danish origins.
Bang placed the move in a wider pattern of shortened corporate names, citing Hennes og Mauritz becoming H&M and Pepsi Cola becoming Pepsi. He attributed the trend to shrinking consumer attention. He also noted that Novo’s largest competitor, Eli Lilly, uses simply Lilly as its brand.
Søren Løntoft Hansen, senior analyst covering Novo for AL Sydbank, supported that point in comments to Ritzau. According to Hansen, the obesity market is far more consumer driven than the traditional medicine market. He said patients now ask their doctor for treatment themselves, which requires a different way of thinking.
Bang added that a new look can also signal internal change to employees. He said the visual shift can mark that the company is something different from before. Per Bang, that is what Doustdar wants to achieve organizationally, financially and in sales.
